Get the latest news, insights, and market updates on ATGE (Adtalem Global Education Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
3 of Wall Street’s Favorite Stocks We Steer Clear Of
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover. Feb 20, 2026 - $ATGE
Ross University School of Medicine Welcomes New Dean
CHICAGO, February 17, 2026--Covista (NYSE: ATGE), America’s largest healthcare educator, today announced Cheryl Holmes, M.D., a fellow of the Royal College of Physicians of Canada with a master's degree in health professions education, as the next dean of Ross University School of Medicine (RUSM) effective March 16. Feb 17, 2026 - $ATGE
Covista Name Change Sparks Questions On Future Direction And Share Performance
Covista Inc., formerly Adtalem Global Education Inc., has officially adopted its new corporate name. The company has updated its bylaws and registered agent details to align with the new identity. Covista continues to trade on the NYSE under the ticker NYSE:ATGE, with a recent share price of $95.52. For investors, the key point is the new Covista name attached to NYSE:ATGE at a recent share price of $95.52. The stock has recorded a 133.2% return over 3 years and a 131.1% return over 5... Feb 16, 2026 - $ATGE
Down 20.9% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround
Adtalem (ATGE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. Feb 13, 2026 - $ATGE
Assessing Covista (ATGE) Valuation After Recent Share Price Weakness
What recent returns say about Covista stock Covista (ATGE) has drawn fresh attention after a mixed run, with the stock showing a 2.4% decline over the past day, a 10% drop over the past week, and a month slide of 18.9%. Over the past 3 months, Covista has fallen 3.7%, while its 1 year total return is a 10.1% decline. Over the longer term, the 3 year and 5 year total returns are both a little over 12x. See our latest analysis for Covista. With the share price at US$92.92 after a recent 1 month... Feb 13, 2026 - $ATGE
Has The Recent Pullback In Covista (ATGE) Opened A Long Term Opportunity?
If you are wondering whether Covista is still good value at around US$95.17 per share, you are not alone. This article is built to help you make sense of that price tag. The stock has recently pulled back, with a 5.3% decline over the last week, an 18.0% decline over the last month, and a 9.4% decline over the past year. This comes even though the 3 year and 5 year returns sit at 135.4% and 139.4% respectively, and the year to date return is an 8.9% decline. Recent coverage has highlighted... Feb 12, 2026 - $ATGE
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple